KIDS Orthopediatrics Corp
Price (delayed)
$26.31
Market cap
$638.98M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.64
Enterprise value
$670.12M
Founded in 2006, OrthoPediatrics is an orthopedic company focused exclusively on advancing the field of pediatric orthopedics. As such it has developed the most comprehensive product offering to the pediatric
Highlights
The revenue rose by 38% year-on-year and by 8% since the previous quarter
The gross profit has increased by 34% year-on-year and by 6% since the previous quarter
The quick ratio has grown by 19% YoY but it has contracted by 4.6% from the previous quarter
The net income has plunged by 80% YoY and by 33% from the previous quarter
The EPS has dropped by 78% year-on-year and by 33% since the previous quarter
Key stats
What are the main financial stats of KIDS
Market
Valuations
Earnings
Shares outstanding
24.29M
Market cap
$638.98M
Enterprise value
$670.12M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.8
Price to sales (P/S)
2.97
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.27
Revenue
$204.73M
Gross profit
$148.6M
Operating income
-$35.01M
Net income
-$37.82M
EBIT
-$39.31M
EBITDA
-$20.23M
Free cash flow
-$41.31M
Per share
Balance sheet
Liquidity
EPS
-$1.64
EPS diluted
-$1.64
Free cash flow per share
-$1.79
Book value per share
$14.64
Revenue per share
$8.87
TBVPS
$12.92
Total assets
$473.21M
Total liabilities
$118.64M
Debt
$76.92M
Equity
$354.57M
Working capital
$203.21M
Debt to equity
0.22
Current ratio
6.98
Quick ratio
3.33
Net debt/EBITDA
-1.54
Margins
Efficiency
Dividend
EBITDA margin
-9.9%
Gross margin
72.6%
Net margin
-18.5%
Operating margin
-17.1%
Return on assets
-8.3%
Return on equity
-10.3%
Return on invested capital
-15.6%
Return on capital employed
-8.9%
Return on sales
-19.2%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
KIDS stock price
How has the Orthopediatrics stock price performed over time
Intraday
5.03%
1 week
7.78%
1 month
13.31%
1 year
-1.39%
YTD
13.5%
QTD
6.82%
Financial performance
How have Orthopediatrics's revenue and profit performed over time
Revenue
$204.73M
Gross profit
$148.6M
Operating income
-$35.01M
Net income
-$37.82M
Gross margin
72.6%
Net margin
-18.5%
The net income has plunged by 80% YoY and by 33% from the previous quarter
The revenue rose by 38% year-on-year and by 8% since the previous quarter
The gross profit has increased by 34% year-on-year and by 6% since the previous quarter
Orthopediatrics's operating income has decreased by 31% YoY and by 21% QoQ
Growth
What is Orthopediatrics's growth rate over time
Valuation
What is Orthopediatrics stock price valuation
P/E
N/A
P/B
1.8
P/S
2.97
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.27
The EPS has dropped by 78% year-on-year and by 33% since the previous quarter
The price to book (P/B) is 47% less than the 5-year quarterly average of 3.2 and 5% less than the last 4 quarters average of 1.8
The equity has declined by 6% year-on-year and by 4.4% since the previous quarter
KIDS's price to sales (P/S) is 66% lower than its 5-year quarterly average of 8.3 and 19% lower than its last 4 quarters average of 3.5
The revenue rose by 38% year-on-year and by 8% since the previous quarter
Efficiency
How efficient is Orthopediatrics business performance
Orthopediatrics's ROE has plunged by 84% YoY and by 36% from the previous quarter
The return on assets has dropped by 73% year-on-year and by 32% since the previous quarter
KIDS's ROIC has plunged by 58% YoY and by 16% from the previous quarter
The return on sales has declined by 32% year-on-year and by 16% since the previous quarter
Dividends
What is KIDS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for KIDS.
Financial health
How did Orthopediatrics financials performed over time
KIDS's total liabilities has surged by 92% year-on-year
Orthopediatrics's current ratio has increased by 28% YoY but it has decreased by 2.6% QoQ
KIDS's debt is 78% smaller than its equity
The equity has declined by 6% year-on-year and by 4.4% since the previous quarter
The debt to equity has grown by 4.8% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.